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Abstract Phospholipase A2 (PLA2) and H202, secreted from 
activated inflammatory cells, play a central role in the tissue 
damage occurring in inflammatory processes. However, while 
exogenous PLA2 alone does not cause cell lysis, it readily does so 
when acting with H202. We have found that H202 degrades cell 
surface proteoglycans, thus rendering the membrane PL 
accessible to hydrolysis by exogenous PLA2. This novel 
mechanism introduces a role for cell surface proteoglycans in 
protection of cells from damage by pro-inflammatory agents, and 
may assign a central role for the combined action of H202 and 
PLA2 in inflammatory and bacteriocidal processes. 
l~;y words: Phospholipase A2; H202; Cell surface 
p~ oteoglycan; Inflammation 
1. Introduction 
Phospholipase A2 (PLA2), which hydrolyses cell membrane 
paospholipids (PL) to produce free fatty acid and lysopho- 
spholipids, plays a major role in inflammatory processes [1,2]. 
"IVe intracellular cytosolic PLA2 (cPLA2) preferentially hy- 
d ~'olyses arachidonic acid (ArAc) containing PL, thus produc- 
il~g the precursor of the eicosanoids, which are mediators of 
cell activation in inflammatory processes [3]. The secreted 
PLAz (sPLAz) is found at high levels in body fluids in inflam- 
n~atory diseases, such as septic shock, arthritis, acute lung 
il jury, psoriasis and bowel disease, and has been implicated 
il the pathophysiology of these diseases [4]. The SPLA2, se- 
creted from activated inflammatory cells into the extracellular 
fl aid [5] hydrolyses cell membrane PL of target cells, and thus 
t~kes a major part in the cell lysis and the subsequent tissue 
d:lmage occurring in these diseases. 
However, previous studies raised the possibility that exo- 
gmous PLA2 alone does not cause cell lysis [6]. In animal 
n~odels the administration of exogenous PLA2 does not in- 
dace inflammation unless a pro-inflammatory background has 
a ready been established [4]. In accordance with this, it has 
b~en shown that the induction of lysis in cultured cells re- 
q aires the combined action of inflammatory agents, such as 
r~'active oxygen species (H202, peroxy radicals), proteases and 
phospholipases [7]. Each of these agents alone may damage 
c~lls only at pharmacological levels, while at physiological 
kvels they are not toxic, and the synergistic action of more 
titan one agent is required to induce cell damage. In accord- 
ance with this we have found that while various types of 
exogenous PLA2 alone do not cause cell damage, they can 
do so when the cells are treated with subtoxic oncentrations 
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of H202 (see Fig. 1). This is in contrast o results obtained 
with a variety of phospholipid membranes (liposomes), which 
are readily hydrolysed by different ypes of PLA2 from var- 
ious sources [8]. This may indicate that target cells have a 
protective mechanism against PLA2, which is eliminated by 
reactive oxygen species when the inflammatory process is ac- 
tivated. 
The present study was undertaken to elucidate the com- 
bined action of H202 and extracellular PLA2 in the hydrolysis 
of cell membrane PL and the subsequent cell damage. For this 
purpose we have studied the PL hydrolysis and cell damage 
induced by treatment of cultured cells with glucose oxidase 
(GO), an H202 generator, and exogenous PLA2. 
2. Materials and methods 
All materials were purchased from Sigma (St. Louis, MO), unless 
specified otherwise. 
2.1. Cell culture 
BGM (green monkey kidney epithelial cells) were grown in 5% CO2 
in DMEM supplemented with 10% FCS and antibiotics (Biological 
Industries, Israel). 
2.2. Induction of cell damage and release of arachidonic acid 
Three kinds of commercially available PLA2s were used: (1) type II, 
Crotalus atrox PLA2, which is of the same type as the human synovial 
fluid PLA2 [4,9]; (2) type I, Naja mocambique PLA2; and (3) bovine 
pancreas PLA2 (type I). Cells were incubated in 1 ml/well of serum- 
free DMEM supplemented with 3 mg/ml BSA. Cells were treated with 
GO (0.4 units/well) or directly with H202 (1 mM) for 1 h. The cells 
were then washed (to avoid possible interference of H202 with the 
action of PLAe itself) and incubated in fresh medium to which the 
PLA~ (2 units/well) was added. 
2.3. Release of cellular arachidonic acid 
BGM cells were labelled with [3H]ArAc (0.5 laCi/24 well plate) 
(Amersham) during inoculation and grown to confluence. Following 
treatment with GO, and/or with exogenous PLA2, the culture medium 
was collected and subjected to lipid extraction i  chloroform:metha- 
nol (1:1). The lipids were chromatographed on silica thin layer plates 
(Whatman), developed in chloroform:methanol:water (65:35:5), and 
the band corresponding to the radioactive ArAc was scraped and 
counted. 
2.4. Hydrolysis of liposomal PL by PLA2 
Phosphatidylcholine (PC) liposomes were interacted with exogenous 
PLA2 as follows [10]: 30 nmol 1-stearoyl,2-ArAc-PC vesicles contain- 
ing 15 nmol lyso-PC and 10 nCi of 1-stearoyl, [2-14C]ArAc PC, in 
Tris-HCl buffer (100 nM, pH 8.0) containing 10 mM CaC12 and 0.1% 
BSA, were incubated with increasing concentrations of either Naja 
mocambique or Crotalus atrox PLA2. Following this treatment the 
released fatty acid was extracted and separated from PL and its radio- 
activity was counted. 
2.5. Degradation of cell surface glycosaminoglycans (GAG) 
Cultured BGM cells were labelled overnight with Na235SO4. The 
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cells were then washed thoroughly and subjected to treatment with 
GO. The culture medium was then collected and chromatographed on 
a Sepharose 6B column (Pharmacia), using PBS as the eluant. 
2.6. PL oxidation 
Following exposure of the cells or liposomes to H202, PL were 
extracted into chloroform:methanol (1:1) and oxidized PL were de- 
termined by the formation of conjugated dienes [11] and by the for- 
mation of malondialdehydes (MDA) [12]. 
2. 7. Determination of cell damage 
2.7.1. Absorption of Neutral red. After treatment, cells were incu- 
bated with a solution of Neutral red in PBS (0.02 mg/ml) for 1 h. The 
cells were then washed extensively, and the absorbed color extracted 
from the cells with ethanol:water:acetic acid (1:1:0.1) and the ab- 
sorbance read at 540 nm [13]. 
2.7.2. Release of SlCr. Cells were labelled with 10 ~tCi/ml 51Cr at 
the time of seeding, and the release of radioactive chromium into the 
culture medium of treated cells was determined [14,15]. 
3. Results and discussion 
Fig. 1 depicts the release of ArAc by cells treated with 
PLA2 after prior treatment with HzO2 or with GO, as well 
as without prior treatment. When the cells were treated with 
exogenous PLA2 alone, little PL hydrolysis was observed. 
This level of PL hydrolysis is practically insignificant as it 
does not induce any cell damage, as measured by both viabil- 
ity staining and the release of 51Cr (not shown). However, 
marked PL hydrolysis occurred when the cells were treated 
with either GO or H202 prior to the treatment with PLA2. 
Fig. 1 shows that the same effect is produced by H202 or 
GO, demonstrating that it is due to the presence of HzOz. 
This was further confirmed by the addition of catalase (which 
decomposes H202) where no PL hydrolysis was obtained. 
Treatment with GO produces a steady concentration of 
H2Oz throughout the course of the experiment, while H202 
itself, added in one dose at the beginning of the experiment, is 
gradually depleted. Accordingly, in some experiments we 
found that direct treatment with GO produces less variable 
results. Therefore in the following experiments only GO was 
used. 
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Fig. 1. Release of ArAc by the sequential treatment of cells with 
H202 and PLA2. BGM cells, prelabelled with [3H]ArAc were 
washed and treated with H202 or GO for 1 h. The cells were then 
washed again and treated with Crotalus atrox PLA2 for 1 h. The re- 
lease of [3H]ArAc was determined as described in section 2. * and 
II, significant at P < 0.005; A, significant at P < 0.01. 
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Fig. 2. Release of ArAc in cells treated with thimerosal. The same 
procedure was followed as in the experiment of Fig. 1, except hat 
in the experiments with thimerosal (TML), 40 laM thimerosal was 
added along with the enzyme. 
Fig. 1 depicts results obtained with type II PLA2, and sim- 
ilar results were obtained with both the Naja and the pancrea- 
tic PLA2 (5-6-fold and 4-5-fold increase, respectively, when 
the cells were treated with both GO and PLA2 compared with 
treatment with PLA2 or GO alone). 
As we have previously shown, the release of ArAc paral- 
leled the cell damage as measured by the release of 51Cr from 
labelled cells [14,15]. This was reconfirmed in the present 
study by determining the percent of viable cells using the 
Neutral red method. Untreated cells were taken as 100%, 
and cells treated with PLA2 had the same absorption at 540 
nm, indicating no loss of viability. Cells treated with PLA2 
following exposure to GO or H202 were only 20% viable, 
while the viability following treatment with GO or H202 
alone was more than 95%, or 85%, when measured by 51Cr 
or Neutral red, respectively. The viablity test, particularly 
with 51Cr, shows that the treatment with H202 is not sufficient 
to make the cells permeable to the exogenous PLAz. It thus 
seems that H202 conditions the cell surface to the action of 
PLA2. 
In search of the mechanism of this phenomenon, we con- 
sidered previous tudies which investigated the effect of H2Oz 
on the level of endogenously produced ArAc. These studies 
reported that H202 enhances the level of fatty acids released 
from the sn2 position of cell membrane PL, and suggested two 
mechanisms which might be relevant o exogenous PLA2: 
(a) H~O2 oxidizes membrane PL, which makes them a better 
substrate for PLA2 [16,17]; (b) H202 inhibits fatty acid rea- 
cylation by depleting the cells of the ATP necessary for the 
reacylation reactions, and perhaps by a direct effect on ara- 
chidonyl-CoA synthetase [18,19]. 
To examine the possibility that the enhanced PL hydrolysis 
observed in the present study is due to lipid oxidation, the 
cells were treated with GO or HzO2 directly, and PL oxida- 
tion was determined by the two methods described in section 
2.6. It was found, by both methods, that in the culture med- 
ium used in this study (DMEM, not containing Cu+), these 
treatments did not cause any lipid oxidation. To confirm this, 
liposomes composed of 1-stearoyl,2-arachidonyl PC were 
treated with H202 in DMEM medium, and again, no lipid 
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F~g. 3. Degradation and release of cell surface GAG by H202. Cul- 
tured BGM cells were labelled overnight with 35SO4, 1.2 mCi per 24 
well plate, then washed and treated with GO for 1 h, as in the ex- 
periment of Fig. 1. The GAG released into the culture medium 
~cre chromatographed and determined as described in section 2. e, 
C tltured medium of H202-treated cells; (3, culture medium of un- 
tT ~ated cells. 
o',idation was detected by either of the two methods. In po- 
s~:ive control experiments, CuC1 (100 gM) was added to the 
c~ ll culture medium and this induced a significant lipid oxida- 
tion (10 nmol MDA/mg cell protein). It should be noted that 
t ie  studies reporting that oxidized PL are better substrates for 
PLA2 were practically all done with lipid membranes [16,17] 
hile no clear evidence for PL oxidation in intact cells by 
I-t202 has been provided. Moreover, as noted above, PLA2 
o:" different ypes and sources easily hydrolyses all kinds of 
li ~osomal PL without prior oxidation. Hence, lipid oxidation 
does not account for the conditioning of cell membrane PL to 
h ~drolysis by exogenous PLA2. 
The possible inhibition of fatty acid reacylation by H202 
does not explain its effect on the release of fatty acid by 
e,,ogenous PLA2 observed here for the following reasons. In 
tt~e present study the hydrolysis of cell membrane PL was 
d~ztermined in the presence of albumin (3 mg/ml), known to 
b nd free fatty acids and prevent their reacylation [20]. In 
addition, to specifically examine the role of reacylation in 
tl~e elevation of free fatty acid levels, the effect of PLA2 and 
(O  on ArAc release was determined in the presence of thi- 
n~erosal, an inhibitor of fatty acid reacylation [20]. In this 
e~periment thimerosal was added after the treatment with 
t202,  along with the treatment with PLA2. As shown in 
tig. 2, thimerosal further elevated the level of free ArAc con- 
s~derably beyond the level obtained by the combination of 
! 202 and PLA2 alone, thus demonstrating that in the pre- 
s,:nce of H202 alone, reacylation is not blocked. Thus, a pos- 
sible inhibition of reacylation by H202 does not account for 
tile enhancement of ArAc release by the application of the 
PLA2 following treatment with GO. Fig. 1 also shows that 
the treatment with GO induced the release of a small but 
significant amount of ArAc. This might be due to specific 
activation of CPLA2 via PKC and MAP kinase as previously 
reported [21]. 
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We then considered previous reports that H202, probably 
through its reactive oxygen derivatives, may oxidize and break 
down proteoglycans [22,23]. We hypothesized that these 
macromolecules, which cover the cell surface, normally pro- 
tect the cell surface lipids from attack by PLA2, and that 
H202 degrades the proteoglycans, thus allowing the enzyme 
access to the membrane PL. To examine this hypothesis, the 
cell GAG were labelled overnight with asSO]-, then washed 
and treated with H202 as in the experiment of Fig. 1 and the 
release of labelled GAG into the extracellular medium was 
determined. It was found that H202 induces the release of a 
considerable amount (about 30%) of labelled GAG from the 
cell surface, while no labelled GAG were released from un- 
treated cells. To confirm the degradation and to characterize 
the molecular weight of the released GAG, the extracellular 
medium from GO-treated and from untreated cells was sub- 
jected to column chromatography. As shown in Fig. 2, H202 
broke the GAG into fragments of 7000-10000 MW, while no 
labelled GAG, in any MW range, were detected in the med- 
ium of untreated cells. H202 has been also shown to inhibit 
proteoglycan synthesis [24]. However, the possible inhibition 
of GAG synthesis does not seem to contribute to the effect 
observed here for the following reasons. As described in sec- 
tion 2, in our experiment, during the GAG labelling period all 
the cells underwent the same treatment, i.e. overnight labelling 
in the absence of H202. The cells were then washed thor- 
oughly and subjected to H202 for 1 h, which is a relatively 
short period of time compared to proteoglycan turnover, the 
half-life of which is usually from hours to days [25,26]. This is 
supported by the present finding (Fig. 3) that in the control 
cells (no H202) no release of GAG to the extracellular med- 
ium was obtained, showing that the GAG turnover in our 
system is too slow to exhibit inhibition of synthesis during 
this short treatment with H202. It is thus plausible to con- 
clude that H202 strips GAG from the cell surface thus expos- 
ing it to the action of exogenous PLA2. 
This conclusion is also supported by an ongoing study, 
showing that hyaluronic acid (HA) protects liposomal PL 
from hydrolysis by snake venom PLA2, but this protection 
is abolished if the HA was degraded by H202 prior to intro- 
duction of the enzyme (unpublished results). In addition, in 
view of the reports that heparin may bind and inhibit PLA2 
[27,28] it is possible that by stripping the cells of GAG, H202 
eliminates this inhibition. 
In conclusion, the present study demonstrates that (1) cell 
surface proteoglycans have a protective role against exogen- 
ous PLA2; (2) in the process of cell damage by the combined 
action of H202 and exogenous PLA2, a major role of H202 is 
in the oxidation and degradation of the cell surface proteo- 
glycan, which renders the cell membrane PL accessible to 
hydrolysis by PEA2. This mechanism may also apply to the 
process by which polymorphonuclear (PMN) cells kill bacter- 
ia. It may be that the PLA2 secreted by PMN is actually 
designed as an anti-bacterial weapon to act in concert with 
reactive oxygen species to kill invading bacteria. This novel 
mechanism, in addition to possible inhibition of fatty acid 
reacylation and PL oxidation by H202, may assign a central 
role to the combined action of H202 and PLA2 in inflamma- 
tory and bactericidal processes. 
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